NCT00512356 - Efficacy and Safety Study of Anti-Adhesion Product in the Prevention of Intraperitoneal Adhesions | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 31, 2000

Primary Completion Date

February 25, 2003

Study Completion Date

April 30, 2003

Conditions

Intraperitoneal Adhesions

Interventions

BIOLOGICAL

Anti-Adhesion Product

Anti-Adhesion Product (AAP) is a biological two-component product of human origin. The components of AAP are lyophilized Anti-Adhesion Protein Concentrate (AAPC), containing fibrinogen, lyophilized Thrombin Concentrate (TC) and the respective diluents for the reconstitution of the components.

Trial Locations (7)

2120

Copenhagen University Hospital, Rigshospitalet Department of Gastroenterologic Surgery, Copenhagen

5000

Odense University Hospital, Surgical Gastroenterology Department, Odense

00 909

Klinika Chirurgii Ogolnej Onkologicznej i Klatiki Piersiowej CSK WAM, Warsaw

02 781

Im. Marii Sklodowskiej-Curie, Centrum Onkologii-Instytut, Warsaw

416 85

Göteborg University, Department of Surgery, Colorectal Unit, Gothenburg

118 83

Söder Sjukhuset, Department of Surgery, Stockholm

451 80

Uddevalla Sjukhus, Kirurg Kliniken, Uddevalla

All Listed Sponsors

lead

Baxter Healthcare Corporation

INDUSTRY